Sign inJoin waitlistJoin the waitlist

Mohan Suntha

, President and CEO, UMMS · University of Maryland, Baltimore

Credentials: · · ·

History

The Wharton School of Business at the University of Pennsylvania
2009
American Cancer Society: University of Maryland School of Medicine-Head & Neck Malignancies
1994–1995
University of Maryland School of Medicine
1991–1994
Sidney Kimmel Medical College at Thomas Jefferson University
1986–1990
Brown University, 1986
1982–1986

Research

Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients
Cancer Prevention Research · 2009 · 230 citations
Role of glutaredoxin in metabolic oxidative stress. Glutaredoxin as a sensor of oxidative stress mediated by H2O2
Journal of Biological Chemistry · 2002 · 216 citations
Effect of the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation Therapy for Patients With Esophageal Cancer: The NRG Oncology RTOG 0436 Phase 3 Randomized Clinical…
JAMA Oncology · 2017 · First of 19 authors · 190 citations

MK
Mark Krasna
23 papers
Martin Edelman
18 papers
Whitney Burrows
15 papers · 2 as a resident
SS
Scott Strome
11 papers
RO
Robert Ord
10 papers
Kevin Cullen
9 papers
LD
Laurence Doyle
9 papers
Rodney Taylor
9 papers
Bruce Greenwald
8 papers
Jeffrey Wolf
8 papers
Joshua Sonett
8 papers · 6 as a resident
Steven Feigenberg
8 papers

Grants

General Clinical Research Center
National Center for Research Resources · M01
Project lead · $495 · University of Maryland Baltimore
2006–2007

Clinical trials

Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer
Principal investigator · Completed · Phase 3
Radiation Therapy Oncology Group
2008–2022
Evaluation of Cetuximab (ERBITUX) and Concurrent Carboplatin, Paclitaxel & Radiotherapy in the Management of Patients With Advanced Locoregional Squamous Cell Carcinomas of the Head and Neck (GCC 0442)
Principal investigator · Completed · Phase 2
University of Maryland, Baltimore
2004–2012
Paclitaxel, Carboplatin, and Radiation Therapy in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer
Principal investigator · Completed · Phase 2
Radiation Therapy Oncology Group
2004–2016
EVALUATION OF AMIFOSTINE FOR MUCOSAL AND HEMOPOETIC PROTECTION AND CARBOPLATIN, TAXOL, RADIOTHERAPY IN THE MANAGEMENT OF PATIENTS WITH HEAD AND NECK CANCER.(GCC 0202)
Principal investigator · Completed · Phase 2
Mohan Suntharalingam
2002–2009